FDA inspection
Good Looks Company, The: FDA inspection ending Nov 10, 1999
FDA inspection 4831 · No Action Indicated (NAI) · Los Angeles, CA
Key facts
| Inspection ID | 4831 |
|---|---|
| Firm | Good Looks Company, The |
| FEI number | 3001662912 |
| Address | 4512 W Jefferson Blvd |
| City | Los Angeles |
| State | CA |
| ZIP | 90016-4005 |
| Fiscal year | 2000 |
| Inspection end date | Nov 10, 1999 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|Generic Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation|OTC Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data